Axon Ligands (TM) - List of New Ligands 2011

	Chemistry Service Platform - CRO in Medicinal Chemistry × close
Axon Ligands (TM) - alphabetic:[A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]

Axon Ligands^TM for Drug Discovery

Prime Source

High Value

High Quality

We make as Drug Standards

Serving diversified application fields

With expertise like CNS reagents

Brand-new like kinase inhibitors...

[e-catalogue available in pdf]

Products - Axon Ligands^TM - List of New Ligands (by date added) 2011 2010 2009 2008

(Back to New Ligands Released) 2011 DEC (-)-Bay-K8644 \| Ca chan. activator (+)-Bay-K8644 \| Ca chan. modulator (S)-WAY100135 \| 5-HT1A antag. (R)-WAY100135 \| 5-HT1A antag. NXY 059 \| radical scavenger A 770041 \| Lck inhibitor EGFR inhibitor [879127-07-8] Apixaban \| Factor Xa inhibitor dl-hCPT \| Topo-1 inhibitor ADL 5859 \| δ opioid agonist AZ 12216052 \| mGluR8 PAM PF 3845 \| FAAH inhibitor VU 0357017 \| M1 PAM MK 0354 \| Naicin partial agonist SEW 2871 \| S1P1 agonist BMS 345541 \| IKK inhibitor WAY 208466 \| 5-HT6 agonist SB 242084 \| 5-HT2C antagonist 2011 NOV PPP \| CYP2B6 inhibitor Brimonidine \| α2 agonist PAC-1 \| Procaspase activator AMD 3100 \| CXCR4 antagonist Kifunensine \| Mannosidase inh. Palomid 529 \| Akt/mTOR inhibitor Venlafaxine \| SNRI Bexarotene \| RXR agonist A 83-01 \| ALK5 inhibitor BI 6727 \| PLK1 inhibitor Tivozanib \| VEGFR inhibitor GB 83 \| PAR2 antagonist 2011 OCT GSK 690693 \| AKT inhibitor AC 220 \| FLT3 inhibitor SLV 319 \| CB1 antagonist BXL 628 \| VDR agonist Temsirolimus \| mTOR inhibitor Bay K8644 \| Ca chan. activator REP 3123 \| MetRS inhibitor REP 8839 \| MetRS inhibitor Orvepitant \| NK1 antagonist	FR 180204 \| ERK inhibitor BIO \| GSK3 inhibitor 2011 SEP OSI 906 \| IGF-1R/IR inhibitor Shz-1 \| Differentiating agent SU 5402 \| FGFR inhibitor BIX 01294 \| HMTase inhibitor RG 108 \| DNA methylation inh. YS 49 \| antithrombotic MDL 201012 \| M3 antagonist STF 083010 \| IRE1 inhibitor PF 02341066 \| c-Met/ALK inh. 2011 AUG KU 55933 \| ATM inhibitor LY 317615 \| PKCβ inhibitor GSK 461364 \| PLK1 inhibitor CYT 387 \| JAK1/2 inhibitor Asoprisnil \| PR modulator RU 58841 \| Antiandrogen AEE 788 \| EGFR/VEGFR inhibitor MK 2206 \| AKT inhibitor Y-27632 \| ROCK inhibitor 2011 JULY R 406 \| Syk inhibitor BAY 73-4506 \| RTK inhibitor BINA \| mGluR2 PAM Danoprevir \| HCV protease inh. PD 173074 \| FGFR inhibitor TWS 119 \| GSK-3β inhibitor SCIO 469 \| p38 MAPK inhibitor 2011 JUN PHA 408 \| IKK-2 inhibitor Digoxin \| HIF-1 inhibitor A 357300 \| MetAP-2 inhibitor LY 334370 \| 5-HT1F agonist Pelitinib \| EGFR inhibitor Reversine \| Dedifferentiation agent Perifosine \| AKT inhibitor CP 547632 \| VEGFR2 inhibitor 2011 MAY PS 47 \| E-isomer of PS48 PS 48 \| PDK1 activator HLI 373 \| HDM2 inhibitor SB 431542 \| ALK5 inhibitor	Thiazovivin \| hESC enhancer Irestatin 9389 \| IRE1 inhibitor S9947 \| IKur channel blocker 2011 APR CP 100356 \| P-gp inhibitor ISOX \| HDAC6 inhibitor MK 0364 \| CB1 inverse agonist Ambrisentan \| ETA antagonist YM 155 \| Survivin suppresant NN 414 \| KATP channel opener AZ 23 \| Trk inhibitor AZ 3146 \| Mps1 inhibitor 2011 MAR HTI 286 \| Tubulin inhibitor CHIR 124 \| CHK1 inhibitor Zaleplon \| Benzodiazepine ago. NSC 23766 \| Rac1 inhibitor CGP 57380 \| MNK1 inhibitor ABT 869 \| RTK inhibitor PF 573228 \| FAK inhibitor GSK 3787 \| PPAR δ antagonist VER 155008 \| Hsp70 inhibitor 2011 FEB Sotrastaurin \| PKC inhibitor CID 755673 \| PKD inhibitor XMD8-92 \| BMK1 inhibitor OSI 420 \| EGFR inhibitor Vildagliptin \| DPP4 inhibitor Ruxolitinib \| JAK1/2 inh. Remogliflozin \| SGLT2 inhibitor NVP-LDE225 \| SMO antagonist SGI 1776 \| Pim inhibitor 2011 JAN Aurora A inhibitor II \| AurA inh. GSK 461364 analog I \| PLK1 inh. GSK 461364 analog II \| PLK1 inh. Aurora A inhibitor I \| AurA inh. CDIBA \| cPLA2 inhibitor PF 4708671 \| S6K1 inhibitor SB 265610 \| CXCR2 antagonist SNS 032 \| CDK 2 inhibitor HMR 1031 \| VLA-4 antagonist NVP 231 \| CerK inhibitor CP 615003 \| GABAA agonist


2012: NEW JAN; 2011: DEC NOV OCT SEP AUG JULY JUN MAY APR MAR FEB JAN; See 2011 2010 2009 2008